General Information of Drug (ID: DM9JQTQ)

Drug Name
GS-5423
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
PubChem CID
12069231
TTD ID
DEU08Q

References

1 ClinicalTrials.gov (NCT04811040) Study to Evaluate the Safety and Efficacy of GS-5423 and GS-2872 in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection. U.S. National Institutes of Health.